Gut hormones, incretin mimetics and gliptins: New understanding and novel therapies in type 2 diabetes
To access this article, please choose from the options below
PII: S1751-9918(07)00039-3
doi:10.1016/j.pcd.2007.04.003
© 2007 Primary Care Diabetes Europe. Published by Elsevier Inc. All rights reserved.
